23andMe CEO Anne Wojcicki joins 'Influencers with Andy Serwer' to weigh in on the Elizabeth Holmes saga and why it had ‘no’ impact on consumer trust of 23andMe.
The wild swings are enough to cause many investors to look for safe havens to park their hard-earned cash. Here's why those chose AbbVie (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD), and Johnson & Johnson (NYSE: JNJ). Prosper Junior Bakiny (AbbVie): Investors looking for safety in this volatile market can't go wrong with AbbVie.
In the latest trading session, Johnson & Johnson (JNJ) closed at $163.93, marking a -0.36% move from the previous day.